Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Evaluation of the Prognostic Role of a Panel of Biomarkers in Stage IB-IIIA Non-small Cell Lung Cancer Patients

ELENI TIMOTHEADOU, DIMOSTHENIS-VASILIOS SKARLOS, EPAMINONDAS SAMANTAS, SAVVAS PAPADOPOULOS, SAM MURRAY, JANA SKRICKOVA, CHRISTOS CHRISTODOULOU, CHRISTOS PAPAKOSTANTINOU, DIMITRIOS PECTASIDES, PAVLOS PAPAKOSTAS, JANA KAPLANOVA, ELENI VRETTOU, MARIA KARINA, PARASKEVAS KOSMIDIS and GEORGE FOUNTZILAS
Anticancer Research November 2007, 27 (6C) 4481-4489;
ELENI TIMOTHEADOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nellitim@hotmail.com
DIMOSTHENIS-VASILIOS SKARLOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EPAMINONDAS SAMANTAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAVVAS PAPADOPOULOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAM MURRAY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANA SKRICKOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTOS CHRISTODOULOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTOS PAPAKOSTANTINOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRIOS PECTASIDES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAVLOS PAPAKOSTAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANA KAPLANOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELENI VRETTOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA KARINA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PARASKEVAS KOSMIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE FOUNTZILAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 6C 4481-4489
PubMed 
18214064

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 30, 2007
  • Revision received July 17, 2007
  • Accepted August 2, 2007
  • Published online November 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ELENI TIMOTHEADOU1,
  2. DIMOSTHENIS-VASILIOS SKARLOS2,
  3. EPAMINONDAS SAMANTAS3,
  4. SAVVAS PAPADOPOULOS4,
  5. SAM MURRAY5,
  6. JANA SKRICKOVA8,
  7. CHRISTOS CHRISTODOULOU2,
  8. CHRISTOS PAPAKOSTANTINOU1,
  9. DIMITRIOS PECTASIDES7,
  10. PAVLOS PAPAKOSTAS6,
  11. JANA KAPLANOVA8,
  12. ELENI VRETTOU1,
  13. MARIA KARINA1,
  14. PARASKEVAS KOSMIDIS4 and
  15. GEORGE FOUNTZILAS1
  1. 1Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki
  2. 2Henry Dynan Hospital, Athens
  3. 3Agii Anargiri Cancer Hospital, Athens
  4. 4Hygeia Hospital, Athens
  5. 5Department of Molecular Genetics, Metropolitan Hospital, Athens
  6. 6Ippokration Hospital, Athens
  7. 7Metaxa Cancer Hospital, Athens, Greece
  8. 8Clinic of Respiratory Diseases, University Hospital, Brno-Bohunica, Czech Republic
  1. Correspondence to: Dr. Eleni Timotheadou, Department of Medical Oncology, Papageorgiou General Hospital, Aristotle University of Thessaloniki School of Medicine, P.O. Box 366, 54124 Thessaloniki, Greece. e-mail: nellitim{at}hotmail.com

Cited By...

  • 16 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6C)
Anticancer Research
Vol. 27, Issue 6C
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Prognostic Role of a Panel of Biomarkers in Stage IB-IIIA Non-small Cell Lung Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Evaluation of the Prognostic Role of a Panel of Biomarkers in Stage IB-IIIA Non-small Cell Lung Cancer Patients
ELENI TIMOTHEADOU, DIMOSTHENIS-VASILIOS SKARLOS, EPAMINONDAS SAMANTAS, SAVVAS PAPADOPOULOS, SAM MURRAY, JANA SKRICKOVA, CHRISTOS CHRISTODOULOU, CHRISTOS PAPAKOSTANTINOU, DIMITRIOS PECTASIDES, PAVLOS PAPAKOSTAS, JANA KAPLANOVA, ELENI VRETTOU, MARIA KARINA, PARASKEVAS KOSMIDIS, GEORGE FOUNTZILAS
Anticancer Research Nov 2007, 27 (6C) 4481-4489;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Evaluation of the Prognostic Role of a Panel of Biomarkers in Stage IB-IIIA Non-small Cell Lung Cancer Patients
ELENI TIMOTHEADOU, DIMOSTHENIS-VASILIOS SKARLOS, EPAMINONDAS SAMANTAS, SAVVAS PAPADOPOULOS, SAM MURRAY, JANA SKRICKOVA, CHRISTOS CHRISTODOULOU, CHRISTOS PAPAKOSTANTINOU, DIMITRIOS PECTASIDES, PAVLOS PAPAKOSTAS, JANA KAPLANOVA, ELENI VRETTOU, MARIA KARINA, PARASKEVAS KOSMIDIS, GEORGE FOUNTZILAS
Anticancer Research Nov 2007, 27 (6C) 4481-4489;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire